NewBridge Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 327

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Investors
  • 5

NewBridge Pharmaceuticals General Information

Description

Operator of a regional specialty platform intended to address the unmet medical needs and serve patients in the region. The company's platform covers the areas of pharmaceuticals and biologics that focus on cancer, diabetes, renal and cardiovascular diseases and other metabolic disorders, enabling patients to get treated when affected by any critical diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Dubai Science Park Towers
  • 17th Floor, North Tower, Al Barsha South2
  • Dubai United Arab Emirates
+971 04
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Biotechnology
Corporate Office
  • Dubai Science Park Towers
  • 17th Floor, North Tower, Al Barsha South2
  • Dubai United Arab Emirates
+971 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NewBridge Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 19-Oct-2026 Announced Generating Revenue
4. Equity Crowdfunding Cancelled Generating Revenue
3. Later Stage VC (Series C) 29-May-2019 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Sep-2010 $12M $16M Completed Generating Revenue
1. Early Stage VC $4M $4M Completed Startup
To view NewBridge Pharmaceuticals’s complete valuation and funding history, request access »

NewBridge Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a regional specialty platform intended to address the unmet medical needs and serve patients in the region.
Pharmaceuticals
Dubai, United Arab Emirates
327 As of 2026

South San Francisco, CA
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NewBridge Pharmaceuticals Competitors (20)

One of NewBridge Pharmaceuticals’s 20 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Pfizer (Vienna) Corporation Vienna, Austria
Merck & Co. Corporation Rahway, NJ
Ability Pharma Private Equity-Backed Cerdanyola, Spain
The Zambon Group Private Debt Financed Bresso, Italy
You’re viewing 5 of 20 competitors. Get the full list »

NewBridge Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NewBridge Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elan (Pharmaceuticals) Corporation Minority
Revelation Partners Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
Kuwait Life Sciences Company Venture Capital Minority
Kuwait Investment Authority Sovereign Wealth Fund Minority
To view NewBridge Pharmaceuticals’s complete investors history, request access »

NewBridge Pharmaceuticals FAQs

  • When was NewBridge Pharmaceuticals founded?

    NewBridge Pharmaceuticals was founded in 2010.

  • Where is NewBridge Pharmaceuticals headquartered?

    NewBridge Pharmaceuticals is headquartered in Dubai, United Arab Emirates.

  • What is the size of NewBridge Pharmaceuticals?

    NewBridge Pharmaceuticals has 327 total employees.

  • What industry is NewBridge Pharmaceuticals in?

    NewBridge Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is NewBridge Pharmaceuticals a private or public company?

    NewBridge Pharmaceuticals is a Private company.

  • What is NewBridge Pharmaceuticals’s current revenue?

    The current revenue for NewBridge Pharmaceuticals is .

  • How much funding has NewBridge Pharmaceuticals raised over time?

    NewBridge Pharmaceuticals has raised $64M.

  • Who are NewBridge Pharmaceuticals’s investors?

    Elan (Pharmaceuticals), Revelation Partners, Burrill & Co, Kuwait Life Sciences Company, and Kuwait Investment Authority have invested in NewBridge Pharmaceuticals.

  • Who are NewBridge Pharmaceuticals’s competitors?

    Genentech, Pfizer (Vienna), Merck & Co., Ability Pharma, and The Zambon Group are some of the 20 competitors of NewBridge Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process